Wolverine Asset Management’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Wolverine Asset Management’s Portfolio FLACU Stock Details FLACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-860	Closed	-$8K	–	2774
2022 Q2	$8K	Sell	860 -156,221	-99%	-$1.55M	﹤0.01%	2060
2022 Q1	$1.57M	Buy	+157,081	New	+$1.56M	0.02%	595
2021 Q3	–	Sell	-788	Closed	-$7K	–	2596
2021 Q2	$7K	Buy	+788	New	+$7.98K	﹤0.01%	2043
2021 Q1	–	Sell	-35,960	Closed	-$373K	–	2365
2020 Q4	$373K	Buy	+35,960	New	+$375K	﹤0.01%	933

Other funds holding FLACU

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Wolverine Asset Management's FLACU Position: Q3 2022 in Review

Wolverine Asset Management sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q3 2022, closing a stake of 860 shares — an estimated $8K sold.

Wolverine Asset Management first reported a position in FLACU in Q4 2020 and held it in 4 quarters. The position peaked at $1.57M in Q1 2022. 14 funds tracked by Wall St. Rank hold FLACU as of Q3 2022.

Wolverine Asset Management reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q3 2022 after selling out during the quarter.
Wolverine Asset Management sold 860 Frazier Lifesciences Acquisition Corporation Unit shares in Q3 2022, an estimated $8K.
Wolverine Asset Management first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 4 quarters.
Wolverine Asset Management's Frazier Lifesciences Acquisition Corporation Unit position peaked at $1.57M in Q1 2022.
14 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q3 2022.

Based on Wolverine Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.